HALEON PLC
LSE:HLN

Watchlist Manager
HALEON PLC Logo
HALEON PLC
LSE:HLN
Watchlist
Price: 380.6 GBX -0.13% Market Closed
Market Cap: 34.5B GBX
Have any thoughts about
HALEON PLC?
Write Note

Operating Margin
HALEON PLC

18.9%
Current
21%
Average
5.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.9%
=
Operating Profit
2.1B
/
Revenue
11.2B

Operating Margin Across Competitors

Country UK
Market Cap 34.7B GBP
Operating Margin
19%
Country JP
Market Cap 121T JPY
Operating Margin
10%
Country FR
Market Cap 181.1B EUR
Operating Margin
19%
Country UK
Market Cap 113.9B GBP
Operating Margin
18%
Country IN
Market Cap 5.5T INR
Operating Margin
22%
Country DE
Market Cap 27.8B EUR
Operating Margin
11%
Country US
Market Cap 26.8B USD
Operating Margin
10%
Country JP
Market Cap 3T JPY
Operating Margin
7%
Country IN
Market Cap 1.1T INR
Operating Margin
21%
Country IN
Market Cap 902.9B INR
Operating Margin
15%
Country US
Market Cap 9.8B USD
Operating Margin
19%
No Stocks Found

HALEON PLC
Glance View

Market Cap
34.8B GBX
Industry
Consumer products

In the bustling world of consumer healthcare, HALEON PLC stands as a luminary figure, emerging with a focused mission: to deliver everyday health with humanity. Spun off from the pharmaceutical giant GlaxoSmithKline, HALEON now charts its independent course, concentrating on the development and distribution of over-the-counter medications, oral health products, and nutritional supplements. Its diverse portfolio includes household names such as Sensodyne, Panadol, and Centrum, demonstrating its wide-reaching impact on consumers’ health routines. These brands are not merely market fixtures; they represent HALEON’s commitment to blending scientific innovation with consumer insights, aiming to enhance well-being across the globe. HALEON’s business model is poised at the intersection of healthcare and retail, thriving through an intricate blend of strategic marketing, global distribution networks, and strong brand equity. By leveraging extensive consumer research data, HALEON aligns its product offerings with the evolving needs and preferences of its audience. The company generates revenue primarily through product sales, employing an omnichannel strategy that ensures product availability across various retail and digital platforms. Its strategic alliances and network with pharmacies, supermarkets, and online marketplaces cement its accessibility and prominence in the market. Additionally, HALEON's stream of revenue is bolstered by its investment in innovation—a key driver that keeps its product lines relevant and competitive in a dynamic healthcare landscape.

HLN Intrinsic Value
334.53 GBX
Overvaluation 12%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.9%
=
Operating Profit
2.1B
/
Revenue
11.2B
What is the Operating Margin of HALEON PLC?

Based on HALEON PLC's most recent financial statements, the company has Operating Margin of 18.9%.